3623 results for «2080»
3623 results
TAVI - Outcomes predictors
22 May 2025 – From EuroPCR 2025
Examine novel predictors of outcomes following TAVI. This session compares a new nutritional risk index against traditional scores for early post-TAVI mortality prediction and evaluates uric acid as a marker for aortic valve calcification and mortality risk in TAVI patients.
Challenging left main PCI in NSTEMI patients
22 May 2025 – From EuroPCR 2025
Address the complexities of left main PCI in NSTEMI patients with challenging clinical presentations. This session discusses management of complex left main bifurcation disease, early graft failure guided by imaging and physiology, revascularization strategies for coronary left main occlusion, PCI complications requiring CTO techniques, and acute...
TAVI and the left ventricular myocardium
23 May 2025 – From EuroPCR 2025
Understand the intricate relationship between TAVI and left ventricular myocardium through discussions on cardiac damage stages, functional remodeling, and pharmacological interventions post-TAVR. This session also reviews prophylactic ECMO support in high-risk patients, offering a comprehensive perspective on optimizing TAVI outcomes.
Treatment of special anatomical scenarios in STEMI patients
23 May 2025 – From EuroPCR 2025
This session examines special anatomical scenarios in STEMI patients, focusing on the impact of bifurcation angles, calcium burden, and active side branch protection techniques. Learn from multicentre registry data and comparative analyses of bifurcation stenting strategies tailored to STEMI care.
Understanding research: insights from a groundbreaking study
22 May 2025 – From EuroPCR 2025
Enhance your understanding of contemporary research in PCI versus CABG with this session. Learn foundational research principles, latest study findings, and how to translate evidence into clinical practice to improve patient communication and outcomes, bridging the gap between research and everyday cardiology care.
Predictors outcome after tricuspid TEER: is there a perfect tool
22 May 2025 – From EuroPCR 2025
Examine predictors of outcome following tricuspid transcatheter edge-to-edge repair (TEER) in this focused session. Review meta-analyses on TEER efficacy, survival benefits in high-risk patients from the EuroTR registry, and prognostic value of MELD?XI score from the TRISPA registry. Learn about TRI.Fr eligibility criteria and validation of...
Refine diagnosis to improve chronic heart failure care
22 May 2025 – From EuroPCR 2025
Refine diagnostic approaches to improve care in chronic heart failure patients. This session covers comparative pulmonary flow measurement techniques, prognostic significance of left atrial strain in mildly reduced ejection fraction, and serum interleukin-33 associations. Additionally, it reviews biopsy sheath contact confirmation during right ventricular biopsy and...
Intracoronary image interpretation: from operator to artificial intelligence
22 May 2025 – From EuroPCR 2025
Explore the evolving landscape of intracoronary image interpretation from operator-dependent assessments to artificial intelligence (AI) assistance. This session features variability analysis between novices and experts in OCT interpretation, AI-driven plaque segmentation and quantification, comparisons of stent expansion assessments by core labs and AI software, and insights...
CTO after CABG: complex but feasible
23 May 2025 – From EuroPCR 2025
Overcome the complexities of chronic total occlusion (CTO) PCI after coronary artery bypass grafting (CABG) with this session highlighting real-world challenging cases. Topics include retrograde recanalization via bypass grafts, management of regretted stents, post-CABG intervention challenges, and advanced techniques such as plaque/flap lift-and-shift to optimize procedural...
Overcoming complex anatomy in NSTEMI
23 May 2025 – From EuroPCR 2025
Explore advanced interventional strategies addressing complex anatomy in NSTEMI patients. This session presents challenging cases including unusual STEMI presentations with cardiogenic shock in Takayasu arteritis, subtotal aorto-ostial lesions in young patients, and management of giant coronary artery aneurysms, emphasizing tailored approaches to optimize outcomes.
Clinical puzzles in structural interventions
11 Sep 2025 – From PCR Rio Valves 2025
Delve into complex clinical puzzles encountered in structural heart interventions. This session presents comparative outcomes in paradoxical low flow versus high gradient severe aortic stenosis post-TAVI, explores manual and automatic CT measurement techniques, evaluates valve-in-valve procedures within mechanical valves through meta-analysis, and discusses TAVI strategies in...
TAVI cases: the unexpected and the unseen
11 Sep 2025 – From PCR Rio Valves 2025
Explore this session to uncover complex and unexpected challenges encountered during TAVI procedures. Cases include incidental findings such as aortic valve annulus pseudoaneurysm, double coronary artery perforation in severe aortic stenosis, and unique scenarios involving self-expanding valve implantation and transseptal access. Learn strategies for managing bioprosthesis...
Tricuspid TEER intraprocedural guidance
12 Sep 2025 – From PCR Rio Valves 2025
Master the intraprocedural guidance essential for successful Tricuspid Transcatheter Edge-to-Edge Repair (TEER). This session provides comprehensive insights into pre-procedural analysis, gap measurement techniques, and step-by-step intraprocedural monitoring with expert tips and tricks.
TAVI in bicuspid aortic stenosis - LIVE Case
29 Sep 2025 – From PCR Gulf Valves 2025
Delve into the management of bicuspid aortic stenosis with this LIVE educational case from Prince Sultan Cardiac Center in Riyadh. Understand treatment options, procedural planning, and device selection while witnessing the safety and feasibility of TAVI in bicuspid anatomy through patient presentation, imaging analysis, and live...
Aortic stenosis doesn't play alone: TAVI in multivalvular and coronary artery disease patients
11 Sep 2025 – From PCR Rio Valves 2025
Managing aortic stenosis becomes even more challenging when it coexists with coronary artery disease (CAD) or multivalvular pathology. For patients with CAD, careful assessment of symptoms, lesion severity, and anatomy guides whether PCI is best performed before, during, or after TAVI, always with future coronary access...
How coronary physiology may help in guiding treatment of NSTEMI
23 May 2025 – From EuroPCR 2025
This session explores the utility of coronary physiology in guiding NSTEMI treatment. Topics include ischemia with non-obstructive arteries, QFR quality assessment, FFR-CT impact, revascularization deferral, and sex differences in FFR-guided strategies for acute myocardial infarction with multivessel disease.
Permanent pacing after TAVI
23 May 2025 – From EuroPCR 2025
Explore predictors and mechanisms leading to permanent pacemaker implantation after TAVI. This session reviews electrophysiological intervals, atrial pacing markers, anatomical risk factors, and outcomes associated with new generation transcatheter heart valves.
EuroIntervention 20th anniversary and annual editorial meeting – All EuroPCR participants welcome
22 May 2025 – From EuroPCR 2025
Mark the 20th anniversary of EuroIntervention with this special annual editorial meeting open to all EuroPCR participants. Reflect on the journal's achievements, discuss future directions, and engage with leaders in interventional cardiology to shape the evolving landscape of cardiovascular research and practice.
Best companion's case on intravascular lithotripsy
23 May 2025 – From EuroPCR 2025
Join this session focusing on intravascular lithotripsy in challenging cases, emphasizing device and drug synergy, IVUS guidance, and strategies to avoid exacerbating complications. Clinical cases demonstrate management of tough calcified lesions with novel approaches.
Refractory heart failure: combining oral therapy and device is key
21 May 2025 – From EuroPCR 2025
Address refractory heart failure management through combined oral therapy and device interventions. This session helps identify patients needing treatment escalation, reviews contemporary cardiovascular intervention indications, and emphasizes achieving optimal synergy between pharmacologic and device-based therapies through clinical case discussions.
